SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: Scott H. Davis who wrote (1016)5/4/1999 2:22:00 PM
From: Pseudo Biologist  Read Replies (2) | Respond to of 1972
 
This suggests some commitment from Merck, wouldn't you say?

Gilmartin said many earlier-stage Merck experimental drugs also hold promise, including a so-called ''naked DNA'' vaccine against the HIV virus that causes AIDS. He said initial data from clinical trials of the vaccine were expected within ''a couple of years.''

(Gilmartin is Merck's CEO)

biz.yahoo.com